| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Syndax Pharmaceuticals Inc (SNDX) has 6 insiders with recent SEC Form 4 filings, including 4 buys and 8 sells. SNDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 491.7K | $10.10M | - | |
| CFO | 140.4K | $2.88M | - | |
| Dir | 100.0K | $2.05M | - | |
| Dir | 79.0K | $1.62M | - | |
| Other | 35.2K | $722.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | Metzger Michael A53 | Chief Executive Officer | Sell | 17,159 | $21.03 | $360,819.45 | -3.4% | - | - | |
| Feb 9, 2026 | Goldan Keith A.46 | Chief Financial Officer | Sell | 3,410 | $21.03 | $71,705.48 | -2.4% | - | - | |
| Sep 8, 2025 | Metzger Michael A53 | Chief Executive Officer | Sale+OE | 157,307 | $16.41 | $2,582,021.37 | -34.5% | +22.4% | - | |
| Aug 18, 2025 | Podlesak Dennis62 | Director | Sale+OE | 57,600 | $15.19 | $875,099.52 | -9.1% | +8.3% | - | |
| Jul 16, 2025 | Goldan Keith A.46 | Chief Financial Officer | Sell | 1,296 | $9.29 | $12,033.36 | -1.4% | +65.5% | - | |
| Jul 16, 2025 | Metzger Michael A53 | Chief Executive Officer | Sell | 7,534 | $9.29 | $69,953.19 | -2.5% | +65.5% | - | |
| May 19, 2025 | Katkin Keith69 | Director | Buy | 10,000 | $9.11 | $91,120.00 | +11.1% | +70.6% | - | |
| May 19, 2025 | Huber Martin H. Jr. | Director | Buy | 5,000 | $8.99 | $44,950.00 | +6.8% | +70.6% | - | |
| May 19, 2025 | Goldan Keith A.46 | Chief Financial Officer | Buy | 3,000 | $0.00 | - | +3.3% | +70.6% | - | |
| May 16, 2025 | Botwood Nicholas A.J. | Head Of R&D, CMO | Buy | 11,765 | $9.00 | $105,826.17 | +50.3% | +62.8% | - |